Cleocare Headquarters & Office Locations

Cleocare (Private) is headquartered in Fairlawn, Ohio, United States. Founded in 2021, the company operates across 4 countries with approximately 30 employees worldwide.

Where is Cleocare's main office?

Cleocare's main headquarters office is located at 3200 W Market St Ste 2, Fairlawn, Ohio 443333315. This serves as the company's primary corporate address and is home to its executive leadership team.

Cleocare regional offices

Beyond its headquarters in Fairlawn, Cleocare maintains 5 offices across 4 countries. Regional offices span 4 countries.

Cleocare contact information

The main switchboard for Cleocare headquarters can be reached at 13308013264. For investor relations, visit cleocare.pt/investor-relations.

What does Cleocare do?

CleoCare is a women’s health startup focused on breast health, early detection, and personalized risk assessment for breast cancer. The company is developing SenseGlove, a sensor-based wearable paired with an AI-powered mobile application that guides breast self-exams, captures quantitative pressure and motion data, and tracks tissue changes to build individual baselines over time. The mobile app provides step-by-step exam guidance, helps ensure full breast coverage, creates personalized risk profiles, and generates actionable reports that can be reviewed by physicians to support clinical decision-making and screening recommendations. CleoCare combines wearable sensing, machine-learning classifiers, and a risk assessment engine designed to support precision prevention and earlier clinical follow-up when meaningful changes are detected. CleoCare operates under a B2B2C model, initially targeting employers and insurers as a preventive health benefit while building the clinical and health-economic evidence needed to support future reimbursement pathways. The company has completed an FDA pre-submission and is planning and conducting clinical studies, including collaborations with institutions such as the University of Alabama at Birmingham (UAB), as it prepares for U.S. market entry and raises a Seed round.